Foundation Fellow Breakthrough Prize NSERC Synergy Awards
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Beckman Center for the History of Chemistry
THE BECKMAN CENTER FOR THE HISTORY OF CHEMISTRY GERHARD HERZBERG Transcript of an Interview Conducted by M. Christine King at The National Research Council of Canada on 5 May 1986 This interview has been designated as Free Access. One may view, quote from, cite, or reproduce the oral history with the permission of CHF. Please note: Users citing this interview for purposes of publication are obliged under the terms of the Chemical Heritage Foundation Oral History Program to credit CHF using the format below: Gerhard Herzberg, interview by M. Christine King at The National Research Council of Canada, Ottawa, Canada, 5 May 1986 (Philadelphia: Chemical Heritage Foundation, Oral History Transcript # 0023). Chemical Heritage Foundation Oral History Program 315 Chestnut Street Philadelphia, Pennsylvania 19106 The Chemical Heritage Foundation (CHF) serves the community of the chemical and molecular sciences, and the wider public, by treasuring the past, educating the present, and inspiring the future. CHF maintains a world-class collection of materials that document the history and heritage of the chemical and molecular sciences, technologies, and industries; encourages research in CHF collections; and carries out a program of outreach and interpretation in order to advance an understanding of the role of the chemical and molecular sciences, technologies, and industries in shaping society. GERHARD HERZBERG 1904 Born in Hamburg, Germany on 25 December Education 1928 Dr. Ing., Darmstadt Technische Universität Professional Experience 1928-1929 Post-doctoral -
Investment in Early Translational Cancer Research in Canada, 2005–2007
Investment in early Translational Cancer research, 2005–2007 a SPeCIaL rePOrT FrOM THe CaNaDIaN CaNCer reSearCH aLLIaNCe’S SurVey OF GOVerNMeNT aND VOLuNTary SeCTOr INVeSTMeNT IN CaNCer reSearCH February 2011 For additional copies of this publication, please contact: Canadian Cancer Research Alliance (CCRA) 1 University Avenue, Suite 300 Toronto, Ontario M5J 2P1 CANADA Tel.: (416) 915-9222, ext. 5739 Fax: (416) 915-9224 Email: [email protected] This publication is also available at the following address http://www.ccra-acrc.ca. It is formatted for two-sided printing. Permission To Reproduce Except as otherwise specifcally noted, the information in this publication may be reproduced, in part or in whole and by any means, without charge or further permission from the Canadian Cancer Research Alliance (CCRA), provided that due diligence is exercised in ensuring the accuracy of the information reproduced, CCRA is identifed as the source institution, and the reproduction is not represented as being an offcial version of the information, or as having been made in affliation with, or with the endorsement of, CCRA. Suggested Citation: Canadian Cancer Research Alliance (2010). Investment in Early Translational Cancer Research, 2005–2007: A Special Report from the Canadian Cancer Research Alliance’s Survey of Government and Voluntary Sector Investment in Cancer Research. Toronto: CCRA. © Canadian Cancer Research Alliance, 2011 ISBN 978-0-9866841-1-1 (print) / ISBN 978-0-9866841-0-4 (PDF) Aussi offert en français sous le titre : Investissements dans les étapes initiales de la recherche translationnelle sur le cancer, de 2005 à 2007 : un rapport spécial sur l’enquête de l’Alliance canadienne pour la recherche sur le cancer sur les investissements effectués dans la recherche sur le cancer par les organismes gouvernementaux et non gouvernementaux. -
Backgrounder Global Centre for Pluralism Mission
Global Centre for Pluralism: Backgrounder Global Centre for Pluralism Mission: The Global Centre for Pluralism serves as a global platform for comparative analysis, education and dialogue about the choices and actions that advance and sustain pluralism. Vision: The Centre’s vision is a world where human differences are valued and diverse societies thrive. The Global Centre for Pluralism is an independent, charitable organization created to advance positive responses to the challenge of living peacefully and productively together in diverse societies. Why Canada Founded in Ottawa by His Highness the Aga Khan in partnership with the Government of Canada, the Centre takes inspiration from Canada’s experience. Respect for diversity has developed into a defining characteristic of Canada and a core element of the country’s identity. Although still a work in progress, Canada is a global leader in the way it has valued and managed its diverse multi-ethnic, multicultural fabric. The Centre’s headquarters will be a platform for analysing and sharing Canada’s ongoing pluralism journey with the world. His Highness the Aga Khan His Highness the Aga Khan is the 49th hereditary Imam (Spiritual Leader) of the Shia Imami Ismaili Muslims. For His Highness the Aga Khan, one manifestation of his hereditary responsibilities has been a deep engagement with development for almost 60 years. Ties with Canada: His Highness has long been interested in Canada’s experience of pluralism. His close ties with Canada go back almost four decades to the 1970s when many thousands of Asian refugees expelled from Uganda, including many Ismailis, were welcomed into Canadian society. -
The Canadian Society of Biochemistry and Molecular & Cellular Biology
Bulletin The Canadian Society of Biochemistry and Molecular & Cellular Biology/ La Société canadienne de biochimie et de biologie moléculaire et cellulaire 2001 www.csbmcb.ca ISSN 1197-6578/2001 COVER PHOTO: A schematic diagram of the Sec dependent protein translocation system [from The 2001 Merck Frosst Prize Award Address Mark Paetzel and Natalie C. J. Strynadka] Contents CSBMCB Board for 2001-2002 ....................................................................................... 4 CSBMCB President’s Report ............................................................................................ 5 Incoming Members of CSBMCB Executive Board 2001-2002 ......................................... 6 IUBMB Toronto Congress Update ................................................................................. 13 Minutes of the 44th CSBMCB Annual General Meeting ................................................ 14 11th Winternational Symposium .................................................................................. 21 44th Annual Meeting of the CSBMCB .......................................................................... 22 Society Awards 2000-2001 ........................................................................................... 27 Workshop On: Myelin Structure And Its Role In Autoimmunity ..................................... 31 Report on the AUUBC................................................................................................... 34 In Memoriam Peter Dolphin .......................................................................................................... -
Curriculum Vitae Arthur B
CURRICULUM VITAE ARTHUR B. MCDONALD Contact Office Dept. of Physics, Engineering Physics and Astronomy, Queen's University Kingston, Ontario, Canada K7L 3N6 Tel: (613) 533-2702 Fax: (613) 533-6813 Academic Experience Position Institution Year Professor Emeritus Queen’s University 2013 - Present Director Sudbury Neutrino Observatory Collaboration 1989 - Present Gordon and Patricia Gray Chair in Particle Astrophysics Queen’s University 2006 - 2013 University Research Chair Queen’s University 2002 - 2006 Director SNO Institute 1991-2003, 2006 - 2009 Associate Director SNOLAB Institute 2009 - 2013 Professor Queen's University 1989 - 2013 Professor Princeton 1982 - 1989 Sr. Research Officer Atomic Energy of Canada 1980 - 1982 (Chalk River, Ontario) Assoc. Research Officer Chalk River 1975 - 1980 Assist. Research Officer Chalk River 1970 - 1975 Postdoctoral Fellow Chalk River 1969 - 1970 Education: Dalhousie University, Halifax, Nova Scotia - B.Sc. Physics (1964) Dalhousie University, Halifax, Nova Scotia - M.Sc. Physics (1965) California Institute of Technology, Pasadena, CA, USA - Ph.D. Physics (1969) Awards: Governor General's Medal, Dalhousie, 1964 Rutherford Memorial Fellowship, (1969-1970) Fellow of the American Physical Society, 1983 LL.D., honoris causa, Dalhousie, 1997 Fellow of Royal Society of Canada, 1997 Honorary Life Membership at Science North, Sudbury, Ontario, 1997 Killam Research Fellowship, 1998 LL.D., honoris causa, University College of Cape Breton, 1999 D. Sc., honoris causa, Royal Military College, 2001 T.W. Bonner Prize -
The Dawning of a National Scientific Community in Canada, 1878-1896 Vittorio M
Document généré le 1 oct. 2021 04:02 HSTC Bulletin Journal of the History of Canadian Science, Technology and Medecine Revue d’histoire des sciences, des techniques et de la médecine au Canada The Dawning of a National Scientific Community in Canada, 1878-1896 Vittorio M. G. de Vecchi Volume 8, numéro 1 (26), juin–june 1984 URI : https://id.erudit.org/iderudit/800182ar DOI : https://doi.org/10.7202/800182ar Aller au sommaire du numéro Éditeur(s) HSTC Publications ISSN 0228-0086 (imprimé) 1918-7742 (numérique) Découvrir la revue Citer cet article de Vecchi, V. M. G. (1984). The Dawning of a National Scientific Community in Canada, 1878-1896. HSTC Bulletin, 8(1), 32–58. https://doi.org/10.7202/800182ar Tout droit réservé © Canadian Science and Technology Historical Association / Ce document est protégé par la loi sur le droit d’auteur. L’utilisation des Association pour l'histoire de la science et de la technologie au Canada, 1984 services d’Érudit (y compris la reproduction) est assujettie à sa politique d’utilisation que vous pouvez consulter en ligne. https://apropos.erudit.org/fr/usagers/politique-dutilisation/ Cet article est diffusé et préservé par Érudit. Érudit est un consortium interuniversitaire sans but lucratif composé de l’Université de Montréal, l’Université Laval et l’Université du Québec à Montréal. Il a pour mission la promotion et la valorisation de la recherche. https://www.erudit.org/fr/ 32 THE DAWNING OF A NATIONAL SCIENTIFIC COMMUNITY IN CANADA, 1878-1896* Vittorio M. G. de Vecchi (1941-1983) The thesis argued in this paper is that the revival undergone by the imperial ideal in Britain and in Canada affected the development of the institutions of science in the Dominion and the values that those institutions represented. -
Journal of Family Practice Oncology
Journal of Family Practice Oncology Issue Number 22, Spring 2014 | www.fpon.ca Insight into BC’s Colon Screening Program By Dr. Jennifer Telford, Medical Director, Registering eligible patients into the program Provincial Colon Screening Program ensures that the BC Cancer Agency receives FIT results and can refer patients with an Since November 15, 2013 the Colon abnormal FIT or those that are higher than Screening Program has been available average risk to one of 20 health authority across the province. Physicians can register patient coordinators for pre-colonoscopy asymptomatic patients ages 50 to 74 in the assessments. Colon Screening Program as follows: Abnormal FIT Results Colon Screening Program For average risk patients: Jennifer Telford MD MPH FRCPC February 20, 2014 FECAL IMMUNOCHEMICAL TEST (FIT) An abnormal FIT indicates that there www.screeningbc.ca/colon may be bleeding from somewhere in the • Select the ‘Fecal Occult Blood, age 50- colon or rectum. Blood can be present 74, asymptomatic q2y (copy to Colon in the stool for many different reasons, Watch Dr. Jennifer Telford’s hour long Screening Program)’ option on the including hemorrhoids, ulcers, anal fissures, Webcast on the BC’s new Provincial updated Standard Outpatient Laboratory diverticular disease, or inflammation. Colon Screening Program at www.fpon.ca Requisition. – CME Initiatives. • A copy of the FIT report will be sent to the Approximately 15% of individuals screened with Colon Screening Program at the BC Cancer FIT will have an abnormal FIT result and will Agency. require colonoscopy. Of those with an abnormal • For colorectal cancer screening in FIT, 4% will have cancer and approximately 60% individuals less than 50 years of age. -
TRIUMF Team Welcomes Isotope Investment
Canada’s national laboratory for particle and nuclear physics Laboratoire national canadien pour la recherche en physique nucléaire et en physique des particules News Release | For Immediate Release | February 28, 2013, 9:00 a.m. PST TRIUMF Team Welcomes Isotope Investment (Vancouver, BC) --- The CycloTech99 consortium welcomes the investment by Natural Resources Canada (NRCan) through the Isotope Technology Acceleration Program (ITAP) and our partners in provinces, universities, and industry. These funds represent a continued investment from NRCan resulting from our earlier efforts during the Non-reactor-based Isotope Supply Contribution Program (NISP). As announced in February 2012, CycloTech99 has demonstrated the capability to produce the world’s most popular medical isotope, technetium-99m, on medical cyclotrons already installed in Ontario and British Columbia. Our solution in ITAP includes regulatory approval and commercial roll out for a truly national technetium production solution for the benefit of all Canadians, by securing medical isotopes for our patients when the NRU reactor in Chalk River ceases production in 2016. We have a clear pathway to address and stabilize this gap. Principal investigator Paul Schaffer leads the team and is head of TRIUMF’s Nuclear Medicine Division. He said, “The federal government has invested in our team to deliver an innovation for the benefit of all Canadians. We look forward to delivering a domestic solution to the medical isotope crisis in the near future.” “The Harper Government is working to find new ways of producing medical isotopes for the diagnosis of heart disease and cancer in Canadians,” said the Honourable Joe Oliver, Canada’s Minister of Natural Resources. -
Vancouver Institute: an Experiment in Public Education
1 2 The Vancouver Institute: An Experiment in Public Education edited by Peter N. Nemetz JBA Press University of British Columbia Vancouver, B.C. Canada V6T 1Z2 1998 3 To my parents, Bel Newman Nemetz, B.A., L.L.D., 1915-1991 (Pro- gram Chairman, The Vancouver Institute, 1973-1990) and Nathan T. Nemetz, C.C., O.B.C., Q.C., B.A., L.L.D., 1913-1997 (President, The Vancouver Institute, 1960-61), lifelong adherents to Albert Einstein’s Credo: “The striving after knowledge for its own sake, the love of justice verging on fanaticism, and the quest for personal in- dependence ...”. 4 TABLE OF CONTENTS INTRODUCTION: 9 Peter N. Nemetz The Vancouver Institute: An Experiment in Public Education 1. Professor Carol Shields, O.C., Writer, Winnipeg 36 MAKING WORDS / FINDING STORIES 2. Professor Stanley Coren, Department of Psychology, UBC 54 DOGS AND PEOPLE: THE HISTORY AND PSYCHOLOGY OF A RELATIONSHIP 3. Professor Wayson Choy, Author and Novelist, Toronto 92 THE IMPORTANCE OF STORY: THE HUNGER FOR PERSONAL NARRATIVE 4. Professor Heribert Adam, Department of Sociology and 108 Anthropology, Simon Fraser University CONTRADICTIONS OF LIBERATION: TRUTH, JUSTICE AND RECONCILIATION IN SOUTH AFRICA 5. Professor Harry Arthurs, O.C., Faculty of Law, Osgoode 132 Hall, York University GLOBALIZATION AND ITS DISCONTENTS 6. Professor David Kennedy, Department of History, 154 Stanford University IMMIGRATION: WHAT THE U.S. CAN LEARN FROM CANADA 7. Professor Larry Cuban, School of Education, Stanford 172 University WHAT ARE GOOD SCHOOLS, AND WHY ARE THEY SO HARD TO GET? 5 8. Mr. William Thorsell, Editor-in-Chief, The Globe and 192 Mail GOOD NEWS, BAD NEWS: POWER IN CANADIAN MEDIA AND POLITICS 9. -
The Royal Society of Canada
CELEBRATING EXCELLENCE AND IMPACT THE ROYAL SOCIETY OF CANADA 2015 ANNUAL REPORT www.rsc-src.ca TABLE OF CONTENTS ABOUT US .............................................................................................................................................................................................................. 2 MESSAGE FROM THE PRESIDENT ....................................................................................................................................................................... 3 MESSAGE FROM THE EXECUTIVE DIRECTOR ..................................................................................................................................................... 4 RSC COUNCIL AND THE SECRETARIAT ................................................................................................................................................................ 5 EXPERT PANELS ................................................................................................................................................................................................... 6 REPORTS FROM ABROAD .................................................................................................................................................................................... 6 INTERNATIONAL ACTIVITIES ................................................................................................................................................................................. 7 WORK OF THE ACADEMIES ................................................................................................................................................................................ -
Taking It Step by Step: a Guide for Women Diagnosed with Gynecological Cancer
Taking it Step by Step A GUIDE FOR WOMEN DIAGNOSED WITH GYNECOLOGICAL CANCER With great thanks In This Guide Taking it Step by Step: A guide for women 1 Understanding Your Diagnosis _________ 3 diagnosed with gynecological cancer was envisioned and created by the BC/Yukon 2 Treatment Pathway & Timelines _______ 5 Women’s Cancer Information & Support Alliance. This group’s collaborative effort 3 Your Cancer Type _______________________6 includes: women with gynecological cancers; Uterine Cancer __________________________________6 the Canadian Cancer Society BC & Yukon; the Ovarian/Fallopian Tube Cancer ________________9 Gynecologic Tumour Group and Supportive Care Cervical Cancer ________________________________12 Professionals, BC Cancer Agency; Ovarian Cancer Vulvar Cancer __________________________________15 Canada Pacific Yukon Region and UBC School of Vaginal Cancer _________________________________17 Physical Therapy. The production and design for Taking it Step 4 Understanding Your Pathology Report _19 by Step was generously funded by the Cancer Program, Public Health Agency of Canada. The 5 Getting Ready _________________________20 views expressed herein do not represent the views of the Public Health Agency of Canada 6 Questions For Your Medical Team _____21 The printing and ongoing evaluation of Taking 7 Other Common Questions ____________22 it Step by Step is generously funded by the BC Cancer Foundation. The BC Cancer Foundation 8 Your Emotions __________________________23 is an independent charitable organization that raises -
Lifesciences 2020 – Innovation in Motion
BIV LIFESCIENCES 2020 OFFICIAL PUBLICATION SPONSOR PUBLISHED BY Get ahead of the pack. Social • Google • Websites • Programmatic Glacier Media Digital experts help businesses succeed online. Contact us for a FREE Digital Audit [email protected] US-CHINA PHASE ONE TRADE DEAL: CHINA’S IP COMMITMENTS TO THE LIFE SCIENCES INDUSTRY Written by Jayde Wood & Jennifer Marles A STRONGER INTELLECTUAL pharmaceutical patent applicants to secure agreements will be to move Canada and PROPERTY REGIME IN THE MAKING patent protection in China. China closer in this area. On 15 January 2020, China and the US China will also be required to establish an OPPORTUNITIES FOR LIFE SCIENCES signed an agreement on a Phase One trade effective mechanism for early resolution of COMPANIES deal, which could significantly improve patent disputes, which includes a system the ability of life sciences companies to provide notice to a patent holder that a China’s IP commitments under this to protect their intellectual property in generic drug company is seeking approval Agreement will likely create new China. The first chapter of the Agreement of a version of its patented drug. Such a opportunities for life sciences companies addresses inadequacies in China’s IP regime would be similar in concept to the wishing to market their innovative products regime. The Agreement states that China Patented Medicines (Notice of Compliance) in China, the world’s second-largest life recognizes the importance of IP protection regime that exists in Canada. sciences market. Companies should closely and believes that enhancing IP protection watch the developments of China’s IP and enforcement will boost innovation, PATENT TERM ADJUSTMENT AND regime so that they can assess the potential grow innovation-driven enterprises, and EXTENSION impact on their business and patenting promote high quality economic growth.